Head to Head Review: Lifecore Biomedical (NASDAQ:LFCR) versus RYTHM (NASDAQ:RYM)

RYTHM (NASDAQ:RYM) and Lifecore Biomedical (NASDAQ:LFCR) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends.

Analyst Ratings

This is a summary of current recommendations for RYTHM and Lifecore Biomedical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RYTHM	1	0	0	0	1.00
Lifecore Biomedical	2	3	0	0	1.60

Lifecore Biomedical has a consensus target price of $6.50, suggesting a potential upside of 1.56%. Given Lifecore Biomedical’s stronger consensus rating and higher probable upside, analysts plainly believe Lifecore Biomedical is more favorable than RYTHM.

Profitability

This table compares RYTHM and Lifecore Biomedical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
RYTHM	9.84%	21.25%	5.51%
Lifecore Biomedical	-56.80%	N/A	-29.53%

Earnings and Valuation

This table compares RYTHM and Lifecore Biomedical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RYTHM	$17.28 million	2.02	-$33.26 million	($5.27)	-3.05
Lifecore Biomedical	$128.87 million	1.88	-$70.51 million	($1.86)	-3.44

RYTHM has higher earnings, but lower revenue than Lifecore Biomedical. Lifecore Biomedical is trading at a lower price-to-earnings ratio than RYTHM, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

6.0% of RYTHM shares are held by institutional investors. Comparatively, 83.4% of Lifecore Biomedical shares are held by institutional investors. 3.5% of RYTHM shares are held by insiders. Comparatively, 32.7% of Lifecore Biomedical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Risk and Volatility

RYTHM has a beta of 9.94, indicating that its share price is 894% more volatile than the S&P 500. Comparatively, Lifecore Biomedical has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.

About RYTHM

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction.

About Lifecore Biomedical

Lifecore Biomedical, Inc. is a contract development and manufacturing organization that provides development, formulation, aseptic filling, packaging and other manufacturing services for pharmaceutical and biopharmaceutical companies. The company specializes in complex sterile injectable products and supports customers from development through commercial production. Lifecore has particular expertise in hyaluronic acid, a naturally occurring substance used in ophthalmic, orthopedic, aesthetic and other medical applications.